跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,096 条关于
“orforglipron calcium”
全部
3,096
临床试验
2,263
药物
389
机构
15
资讯
429
去年
Oral GLP-1R Obesity Drugs Race to Market as Novo Nordisk and Eli Lilly Lead Phase III Trials
2年前
Orforglipron Shows Promise in Reducing Cardiovascular and Inflammatory Markers in Phase II Trial
去年
Eli Lilly's Orforglipron Shows Promise as Oral GLP-1 Therapy Advances
去年
Eli Lilly Anticipates Orforglipron Approval for Weight Loss by Early 2026
去年
Eli Lilly's Weight-Loss Pill Orforglipron Aims for FDA Approval by 2026
去年
Lilly's Oral GLP-1 Orforglipron Shows Promising Results in Phase 3 Trial
去年
Eli Lilly's Oral GLP-1 Orforglipron Shows Promising Phase 3 Results for Weight Management
去年
Eli Lilly's Orforglipron: Daily Weight-Loss Pill Shows Promise in Phase 3 Trial for Obesity and Diabetes
去年
Eli Lilly's Oral Diabetes Drug Orforglipron Shows Promise in Phase 3 Trial, Offering Alternative to Injectable GLP-1 Therapies
9个月前
Calcium-Activated Switch Enhances Antibody-Drug Conjugate Delivery and Potency in Cancer Treatment
第 1 页,共 43 页
上一页
下一页